相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ketamine and depression: a narrative review
Alexandrine Corriger et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
Michael F. Grunebaum et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Maintenance Ketamine Therapy for Treatment-Resistant Depression
Shaina Archer et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2018)
Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion
Mu-Hong Chen et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression
Wei Zheng et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression
Yanling Zhou et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study
Chen Mu-Hong et al.
PSYCHIATRY RESEARCH (2018)
Addictive potential of novel treatments for refractory depression and anxiety
Dusan Kolar
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
Ketamine augmentation rapidly improves depression scores in inpatients with treatment-resistant bipolar depression
Janusz K. Rybakowski et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2017)
Low-dose ketamine for treatment resistant depression in an academic clinical practice setting
David Feifel et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Ketamine for Depression, 3: Does Chirality Matter?
Chittaranjan Andrade
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action
Chittaranjan Andrade
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
Tung-Ping Su et al.
NEUROPSYCHOPHARMACOLOGY (2017)
The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder
Chadi G. Abdallah et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression When Enough Is Enough
Charles R. Conway et al.
JAMA PSYCHIATRY (2017)
Ketamine use in current clinical practice
Mei Gao et al.
ACTA PHARMACOLOGICA SINICA (2016)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B. Singh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications
Melvyn W. Zhang et al.
BMC MEDICAL ETHICS (2016)
Continuation phase intravenous ketamine in adults with treatment resistant depression
Jennifer L. Vande Voort et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement
Jessie McGowan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder
J. W. Murrough et al.
TRANSLATIONAL PSYCHIATRY (2015)
A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
A. McGirr et al.
PSYCHOLOGICAL MEDICINE (2015)
Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
Paulo R. Shiroma et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression
Paulo R. Shiroma et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
The Use of a Series of Ketamine Infusions in Two Patients With Treatment-Resistant Depression
Michael Messer et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2014)
Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder
Mehdi Ghasemi et al.
PSYCHIATRY RESEARCH (2014)
Ketamine administration in depressive disorders: a systematic review and meta-analysis
Guillaume Fond et al.
PSYCHOPHARMACOLOGY (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A Preliminary Positron Emission Tomography Study
Paul J. Carlson et al.
BIOLOGICAL PSYCHIATRY (2013)
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
James W. Murrough et al.
BIOLOGICAL PSYCHIATRY (2013)
Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?
Janusz K. Rybakowski et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2013)
Serial infusions of low-dose ketamine for major depression
Keith G. Rasmussen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study
Cheng-Ta Li et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression
Giacomo Salvadore et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Rapid decrease in depressive symptoms with an N-methyl-D-aspartate antagonist in ECT-resistant major depression
Lobna Ibrahim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
How to do a meta-analysis
Andy P. Field et al.
BRITISH JOURNAL OF MATHEMATICAL & STATISTICAL PSYCHOLOGY (2010)
Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
Rebecca B. Price et al.
BIOLOGICAL PSYCHIATRY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Definition, assessment, and staging of treatment-resistant refractory major depression: A review of current concepts and methods
Marcelo T. Berlim et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Report by the ACNP Task Force on response and remission in major depressive disorder
A. John Rush et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
S Duval et al.
BIOMETRICS (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
